Randomized, Double Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease

被引：0
|
作者：
Rosas, I. [1 ]
Solomon, J. [2 ]
Donoff, S. [3 ]
Woodhead, F. [4 ]
Raghu, G. [5 ]
Hilary, G. [6 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Colorado, Denver, CO 80202 USA
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[4] Univ Leicester, Leicester, Leics, England
[5] Univ Washington, Seattle, WA 98195 USA
[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[7] TRAIL NETWORK, Seattle, WA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.4534
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
4534
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Safety and Efficacy of Ferula asafoetida in Functional Dyspepsia: A Randomized, Double-Blinded, Placebo-Controlled Study
    Mala, K. N.
    Thomas, Jestin
    Syam, Das S.
    Maliakel, Balu
    Krishnakumar, I. M.
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [22] Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis Interstitial Lung Disease
    Khanna, Dinesh
    Albera, Carlo
    Fischer, Aryeh
    Seibold, James R.
    Khalidi, Nader A.
    Raghu, Ganesh
    Chung, Lorinda
    Schiopu, Elena
    Chen, Dan
    Gorina, Eduard
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [23] A Randomized Double Blinded Placebo Controlled Study of Probiotics in Active Rheumatoid Arthritis (RA)
    Pineda, Maria
    Thompson, Sarah
    Reid, Gregor
    De Leon, Faye
    Pope, Janet
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1305 - 1305
  • [24] A Multinational Phase 2, Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study to Evaluate the Safety and Efficacy of FP-045, An Aldehyde Dehydrogenase 2 Activator in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease
    Elmankabadi, B.
    Lee, Y.
    Yang, W.
    Boudreau, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [25] Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis
    Ryan, C.
    Menter, A.
    Guenther, L.
    Blauvelt, A.
    Bissonnette, R.
    Meeuwis, K.
    Sullivan, J.
    Cather, J. C.
    Yosipovitch, G.
    Gottlieb, A. B.
    Merola, J. F.
    Duffin, K. Callis
    Fretzin, S.
    Osuntokun, O. O.
    Burge, R.
    Naegeli, A. N.
    Yang, F. E.
    Lin, C. -Y.
    Todd, K.
    Bleakman, A. Potts
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (04) : 844 - 852
  • [26] Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo-controlled, double-blinded study
    Youn, Sang Woong
    Jo, Seong Jin
    Park, Chul Jong
    Kim, Dong Hyun
    Shin, Bong Seok
    Jeong, Ki Heon
    Bang, Chul Hwan
    Cross, Nancy
    Thirlwell, Jackie
    Hoepken, Bengt
    JOURNAL OF DERMATOLOGY, 2024, 51 (11): : 1392 - 1403
  • [27] Clinical efficacy and tolerability evaluation of pentoxifylline in rheumatoid arthritis - A double-blind, randomised, placebo-controlled study
    Usha, PR
    Naidu, MUR
    Datla, R
    CLINICAL DRUG INVESTIGATION, 2002, 22 (05) : 329 - 339
  • [28] A randomized double-blind placebo-controlled phase 2 study on the efficacy and safety of fasudil in patients with stable angina
    Vicari, RM
    Chaitman, B
    Keefe, D
    Smith, WB
    Chrysant, ST
    Tonkon, MJ
    Bittar, N
    Weiss, RJ
    Thadani, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 254A - 254A
  • [29] A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis
    Guntupalli, Kalpalatha
    Dean, Nathan
    Morris, Peter E.
    Bandi, Venkata
    Margolis, Benjamin
    Rivers, Emanuel
    Levy, Mitchell
    Lodato, Robert F.
    Ismail, Preeti M.
    Reese, Amber
    Schaumberg, John P.
    Malik, Rajesh
    Dellinger, R. Phillip
    CRITICAL CARE MEDICINE, 2013, 41 (03) : 706 - 716
  • [30] A randomized, placebo-controlled, phase 2 study of the efficacy and safety of droxidopa in patients with intradialytic hypotension
    Vannorsdall, Mark D.
    Hariachar, Srinivas
    Hewitt, L. Arthur
    POSTGRADUATE MEDICINE, 2015, 127 (02) : 133 - 143
12345